Asia-Pacific IVF Services Market: Segmented: by Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle and Donor Egg IVF cycle); By End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) and Region - Analysis of Market Size, Share & Trends for 2018 and Forecasts to 2030
Asia-Pacific IVF Services Market is anticipated to surpass USD 30 billion by 2030 from USD 9 billion in 2020 at a CAGR of 13% throughout the forecast period, i.e. 2020-2030.
IVF requires sperm fertilization out of the body of a woman and implantation of the cell outside the womb. This is a form of treatment focused on assisted reproductive technology (ART) that helps with child reproduction and is used to treat fertility or genetic defects. It is the fertilizing process, involving the diffusion of eggs, sperm cell recovery, and a manual combination of egg and sperm in a laboratory environment to create an embryo. During further gestation, the embryo(s) are passed into the womb.
The growth of the Asia-Pacific IVF facilities market is driven by delayed female pregnancies, increased infertility levels, and increased gamete donations, higher discretionary income, and rising IVF levels. Low understanding and complications associated with IVF therapy inhibit the development of the market. The development of fertility clinics, on the other hand, will generate new opportunities over the next few years.IVF is one of the most popular procedures that allow couples to cure infertility issues, single moms, and the LGBT community can also help with these procedures. Also, the increase in fertility tourism offers a stable possibility of growth in the Asia-Pacific IVF service market. Moreover, the future of the Asia-Pacific IVF market is projected to raise fertility clinics and expand opportunities in the market.
Asia-Pacific IVF Services Market Expected Market Growth
Based on the end-users, the category of fertility clinics accounted for almost three-fifths of the total market share in 2019, and its advantageous position during the forecast period is projected. But from 2019 to 2030, the fastest CAGR of 14 percent is anticipated in the hospital group. The cycle-based group, which contributed almost two-thirds of the market share in 2018, held the greatest share of the fresh cycle(non-donor group) and is predicted to continue the largest share over the forecast period of 2019-2030. Also, the highest CAGR of 12.5 percent from 2019 to 2030 is expected in this section.
Opportunities for the Players
Asia-Pacific offers the IVF players fruitful prospects due to its large population base, increase in IVF therapy awareness in developing nations of Asia-Pacific, a lower cost of IVF care, an increase in the infertile population, and an increase in spending power. Eggs developed by the reproductive system for older women (more than 40 years of age) are not completely formed for fertilization. The threat of genetic diseases in the egg is therefore high. The development of healthy eggs is decreased for aged individuals and the risk of failure is increased. The development of the IVF market is thus expected to raise the pattern of delayed pregnancy in women.
Increase in Urban Trends
The demand for services of Asia-Pacific IVF is marked by improved living conditions, a growing number of families delaying pregnancy due to professional obligations, and financial stability patterns. Furthermore, massive growth in the services sector in these regions has resulted in stress and unhealthy lifestyles, the major source of infertility among men and women. The fast rise in nuclear families in advanced developing nations, such as India and China, has led to worry for the appropriate child-rearing among young couples which leads to parental delays.
Lack of Awareness
In some developing countries, difficulties involved with IVF treatment like multiple pregnancies and birth defects hinder market growth. In the Asia-Pacific region, many underdeveloped countries lack the knowledge and awareness of IVF. The lack of knowledge in emerging economies like Nigeria, and Indonesia, among others, is a major problem. Understanding and exposure to low-cost embryo transfers can be achieved by medical tourism. This is expected to offer market players a great opportunity to raise awareness leading to boosting their market growth and market size.
The cost and lower chances of success in services are the main restricting factors of this industry. During the first stage of embryo delivery, patients might not conceive. To facilitate pregnancy, patients must endure several processes and this raises the total costs. This operation costs about USD 3,000-USD 8,000 on average. This is a significant obstacle for people with low incomes when using the technique.
The region segment can be further divided into five major types including China, India, Japan, Korea, and others.
Australian Concept Infertility Medical Center (ACIMC)
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk AnalysisRecent Development, Regional Presence, SWOT Analysis
The Asia-Pacific IVF Market size was estimated at USD 9 billion in 2020 and is expected to reach USD 30 billion by 2030
Apollo Hospitals Dhaka Bahasa Fertility Centre Bangkok IVF center Bloom Fertility and Healthcare Bloom Fertility Center Bourn Hall Fertility Center Bumrungrad International Hospital Center for Advanced Reproductive Medicine and Infertility CHA Fertility Center Other Prominent Players
Based on the end-users segment is anticipated to hold the Asia-Pacific IVF Market
Drivers Opportunities for the Players
IVF requires sperm fertilization out of the body of a woman and implantation of the cell outside the womb. This is a form of treatment focused on assisted reproductive technology (ART) that helps with child reproduction and is used to treat fertility or genetic defects.
Select License Type
US : +1 (716) 218-3733
UK : +44 (208) 1235555
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT